乳腺癌分子医学专题 |
|
|
|
|
微小RNA-29b对乳腺癌细胞增殖和迁移的影响及其分子生物学机制 |
姜贻乾1,2, 郭庆敏2, 谷建钟3, 徐小平2, 安素红2, 苏芳2, 鲍艳红2, 黄常新2, 管晓翔1 |
1. 南京医科大学金陵临床医学院, 江苏 南京 210002;
2. 杭州师范大学医学院附属杭州市萧山区第一人民医院肿瘤中心, 浙江 杭州 311200;
3. 浙江中医药大学附属第一医院肿瘤科, 浙江 杭州 310006 |
|
Effect of microRNA-29b on proliferation and migration of breast cancer cells and its molecular mechanism |
JIANG Yiqian1,2, GUO Qingmin2, GU Jianzhong3, XU Xiaoping2, AN Suhong2, SU Fang2, BAO Yanhong2, HUANG Changxin2, GUAN Xiaoxiang1 |
1. Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, China;
2. Center of Oncology, Xiaoshan First people's Hospital Affiliated to the Medical College, Hangzhou Normal University, Hangzhou 311200, China;
3. Department of Oncology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China |
引用本文:
姜贻乾 等. 微小RNA-29b对乳腺癌细胞增殖和迁移的影响及其分子生物学机制[J]. 浙江大学学报(医学版), 2017, 46(4): 349-356.
JIANG Yiqian, GUO Qingmin, GU Jianzhong, XU Xiaoping, AN Suhong, SU Fang, BAO Yanhong, HUANG Changxin, GUAN Xiaoxiang. Effect of microRNA-29b on proliferation and migration of breast cancer cells and its molecular mechanism. Journal of ZheJiang University(Medical Science), 2017, 46(4): 349-356.
链接本文:
http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2017.08.02
或
http://www.zjujournals.com/xueshu/med/CN/Y2017/V46/I4/349
|
[1] CORBIN R, OLSSON-CARTER K, SLACK F. The role of microRNAs in synaptic development and function[J]. BMB Rep,2009,42(3):131-135.
[2] LAGOS-QUINTANA M, RAUHUT R, LENDECKEL W, et al. Identification of novel genes coding for small expressed RNAs[J]. Science,2001,294(5543):853-858.
[3] PENG J, ZARNESCU D C, CEMAN S, et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway[J]. Nat Neurosci,2004,7(2):113-117.
[4] ZHANG Y, ZHAO F J, CHEN L L, et al. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer[J]. Oncotarget,2014,5(23):12291-12303.
[5] TEOH S L, DAS S. The role of microRNAs in diagnosis, prognosis, metastasis and resistant cases in breast cancer[J]. Curr Pharm Des,2017,23(12):1845-1859.
[6] BERTOLI G, CAVA C, CASTIGLIONI I. MicroRNAs:new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer[J]. Theranostics,2015,5(10):1122-1143.
[7] HUANG W. MicroRNAs:biomarkers, diagnostics, and therapeutics[J]. Methods Mol Biol,2017,1617:57-67.
[8] CHUA J H, ARMUGAM A, JEYASEELAN K. MicroRNAs:biogenesis, function and applications[J]. Curr Opin Mol Ther,2009,11(2):189-199.
[9] DOSTIE J, MOURELATOS Z, YANG M, et al. Numerous microRNPs in neuronal cells containing novel microRNAs[J]. RNA,2003,9(2):180-186.
[10] LANG N, LIU M, TANG Q L, et al. Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines[J]. Chin J Cancer,2010,29(6):603-610.
[11] EYHOLZER M, SCHMID S, WILKENS L, et al. The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML[J]. Br J Cancer,2010,103(2):275-284.
[12] 陈万青,郑荣寿.中国女性乳腺癌发病、死亡和生存状况[J].中国肿瘤临床,2015,42(13):668-674. CHEN Wanqing, ZHENG Rongshou. Incidence,mortality and survival analysis of breast cancer in China[J]. Chinese Journal of Clinical Oncology,2015,42(13):668-674. (in Chinese)
[13] 郑莹,吴春晓,张敏璐.乳腺癌在中国的流行状况和疾病特征[J].中国癌症杂志,2013,23(8):561-569. ZHENG Ying, WU Chunxiao, ZHANG Minlu. The epidemic and characteristics of female breast cancer in China[J]. China Oncology,2013,23(8):561-569. (in Chinese)
[14] BARTEL D P. MicroRNAs:genomics, biogenesis, mechanism, and function[J]. Cell,2004,116(2):281-297.
[15] MISKIEWICZ J, TOMCZYK K, MICKIEWICZ A, et al. Bioinformatics study of structural patterns in plant microRNA precursors[J]. Biomed Res Int,2017,2017:6783010.
[16] ZHANG B, PAN X, COBB G P, et al. Plant microRNA:a small regulatory molecule with big impact[J]. Dev Biol,2006,289(1):3-16.
[17] GARZON R, HEAPHY C E, HAVELANGE V, et al. MicroRNA 29b functions in acute myeloid leukemia[J]. Blood,2009,114(26):5331-5341.
[18] MOTT J L, KURITA S, CAZANAVE S C, et al. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB[J]. J Cell Biochem,2010,110(5):1155-1164.
[19] SHAH N R, CHEN H. MicroRNAs in pathogenesis of breast cancer:Implications in diagnosis and treatment[J]. World J Clin Oncol,2014,5(2):48-60.
[20] YAN B, GUO Q, FU F J, et al. The role of miR-29b in cancer:regulation, function, and signaling[J]. Onco Targets Ther,2015,8:539-548.
[21] WANG C, BIAN Z, WEI D, et al. miR-29b regulates migration of human breast cancer cells[J]. Mol Cell Biochem,2011,352(1-2):197-207.
[22] 范旭龙,吴爱国.微小RNA 29在乳腺癌中的研究进展[J/CD].中华乳腺病杂志:电子版,2013,7(5):355-359. FAN Xulong, WU Aiguo. Research progress on microRNA 29 in breast cancer[J/CD]. Chinese Journal of Breast Disease (Electronic Version),2013,7(5):355-359. (in Chinese)
[23] DENG X, CAO M, ZHANG J, et al. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer[J]. Biomaterials,2014,35(14):4333-4344.
[24] WANG Y, ZHANG X, LI H, et al. The role of miRNA-29 family in cancer[J]. Eur J Cell Biol,2013,92(3):123-128.
[25] ZHANG K, ZHANG C, LIU L, et al. A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modulation of VEGF[J]. Int J Clin Exp Pathol,2014,7(9):5701-5708.
[26] ZHANG W, QIAN J X, YI H L, et al. The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression[J]. Mol Biol (Mosk),2012,46(4):622-627.
[27] WANG C, GAO C, ZHUANG J L, et al. A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7[J]. J Cancer Res Clin Oncol,2012,138(12):2127-2136.
[28] CHOU J, LIN J H, BRENOT A, et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression[J]. Nat Cell Biol,2013,15(2):201-213. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|